These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 19721488)

  • 1. [Solid guidelines for prevention of cardiovascular diseases].
    Madsen S; Gjelsvik B; Kjeldsen SE; Klemsdal TO; Meland E; Narvesen S; Norheim OF; Njølstad I; Tonstad S; Ulvin F
    Tidsskr Nor Laegeforen; 2009 Aug; 129(16):1660. PubMed ID: 19721488
    [No Abstract]   [Full Text] [Related]  

  • 2. [Statins and the industry].
    Kjellevand TO
    Tidsskr Nor Laegeforen; 2009 Nov; 129(21):2264. PubMed ID: 19898587
    [No Abstract]   [Full Text] [Related]  

  • 3. [The Medical Products Agency's new guidelines for primary prevention of cardiovascular diseases. No help to physicians].
    Berglund G
    Lakartidningen; 2006 Nov 22-28; 103(47):3694-5. PubMed ID: 17212315
    [No Abstract]   [Full Text] [Related]  

  • 4. [Statins and diabetes--indications and refusal rules].
    Claudi T; Birkeland K; Jensen T
    Tidsskr Nor Laegeforen; 2003 May; 123(11):1564-5. PubMed ID: 12822023
    [No Abstract]   [Full Text] [Related]  

  • 5. Principles for national and regional guidelines on cardiovascular disease prevention.
    Smith S; Voûte J; Fuster V
    Nat Clin Pract Cardiovasc Med; 2006 Sep; 3(9):461. PubMed ID: 16932757
    [No Abstract]   [Full Text] [Related]  

  • 6. Preface cardiovascular disease prevention: the continuum of primary and secondary prevention.
    Deedwania P
    Cardiol Clin; 2011 Feb; 29(1):xi-xiii. PubMed ID: 21257096
    [No Abstract]   [Full Text] [Related]  

  • 7. Polish Forum for Prevention Guidelines on cardiovascular diseases prevention in children and adolescents.
    Stańczyk J; Kierzkowska B; Podolec P; Kopeć G; Cybulska B; Zdrojewski T; Pajak A; Undas A; Godycki-Cwirko M; Drygas W; Rynkiewicz A; Czarnecka D; Naruszewicz M; Opala G; Kozek E; Piotrowicz R; Windak A; Department of Paediatric Cardiology
    Kardiol Pol; 2010 May; 68(5):605-8. PubMed ID: 20491035
    [No Abstract]   [Full Text] [Related]  

  • 8. [Reply concerning the new Medical Products Agency's guidelines for primary prevention of cardiovascular diseases. Issuing recommendations based on available evidence basis an ethical duty].
    Beermann B
    Lakartidningen; 2006 Nov 22-28; 103(47):3731-2. PubMed ID: 17212324
    [No Abstract]   [Full Text] [Related]  

  • 9. [Guidelines, recommendations and positions].
    Hense HW
    Dtsch Med Wochenschr; 2000 Jul; 125(28-29):851. PubMed ID: 10943213
    [No Abstract]   [Full Text] [Related]  

  • 10. The heart of the matter: reducing CVD risk.
    Hayman LL; Kamau MW; Stuart-Shor EM
    Nurse Pract; 2009 May; 34(5):30-5. PubMed ID: 19390396
    [No Abstract]   [Full Text] [Related]  

  • 11. [JUPITER no support of changed guidelines for cardiovascular prevention. Moderate absolute risk reduction and uncertain long term effects].
    Håkansson J
    Lakartidningen; 2009 May 20-Jun 2; 106(21-22):1460-1. PubMed ID: 19579433
    [No Abstract]   [Full Text] [Related]  

  • 12. Polish forum for prevention guidelines on cardiovascular diseases prevention in women.
    Kornacewicz-Jach Z; Podolec P; Kopeć G; Pajak A; Zdrojewski T; Naruszewicz M; Stańczyk J; Undas A; Kozek E; Tykarski A; Opala G; Windak A; Torbicki A; Musiał J
    Kardiol Pol; 2007 Mar; 65(3):334-7. PubMed ID: 17615665
    [No Abstract]   [Full Text] [Related]  

  • 13. Polish Forum for Prevention Guidelines on the so-called new cardiovascular risk factors and markers, which have a potentially significant role in the strategy for the prevention of cardiovascular diseases.
    Undas A; Podolec P; Kopeć G; Pajak A; Gasior Z; Małecki M; Pasowicz M; Rynkiewicz A; Torbicki A; Zdrojeski T; Czarnecka D; Drygas W; Godycki-Cwirko M; Kozek E; Naruszewicz M; Opala G; Stańczyk J; Sieradzki J
    Kardiol Pol; 2007 Nov; 65(11):1396-8. PubMed ID: 18303602
    [No Abstract]   [Full Text] [Related]  

  • 14. [HDL in the guidelines of cardiovascular diseases prevention].
    Rynkiewicz A; Bellwon J
    Kardiol Pol; 2005 Jun; 62 Suppl 2():II17-24. PubMed ID: 19813330
    [No Abstract]   [Full Text] [Related]  

  • 15. [Spanish adaptation of the European Guidelines on Cardiovascular Disease Prevention].
    Brotons C; Royo-Bordonada MA; Alvarez-Sala L; Armario P; Artigao R; Conthe P; de Alvaro F; de Santiago A; Gil A; Lobos JM; Maiques A; Marrugat J; Mauricio D; Rodriguez-Artalejo F; Sans S; Suarez C;
    Neurologia; 2004 Oct; 19(8):438-9. PubMed ID: 15470584
    [No Abstract]   [Full Text] [Related]  

  • 16. [Presentation: European practice guidelines for the prevention of cardiovascular diseases in clinical practice].
    Di Pasquale G
    G Ital Cardiol (Rome); 2008 Jan; 9(1):9-10. PubMed ID: 18383762
    [No Abstract]   [Full Text] [Related]  

  • 17. European guidelines on cardiovascular disease prevention.
    Boysen G
    Int J Stroke; 2009 Apr; 4(2):71. PubMed ID: 19383045
    [No Abstract]   [Full Text] [Related]  

  • 18. Comments on the European guidelines on cardiovascular disease prevention.
    Aessopos A; Farmakis D
    Eur Heart J; 2004 Apr; 25(7):619; author reply 620. PubMed ID: 15120062
    [No Abstract]   [Full Text] [Related]  

  • 19. [Italian application of the European practice guidelines for prevention of cardiovascular diseases].
    Giampaoli S; Riccio C; Vanuzzo D
    G Ital Cardiol (Rome); 2008 Jan; 9(1):60-7. PubMed ID: 18383764
    [No Abstract]   [Full Text] [Related]  

  • 20. [New European guidelines on cardiovascular disease prevention in relation to the situation in Poland].
    Szostak WB; Cybulska B; Kłosiewicz-Latoszek L; Nowicka G; Szostak-Wegierek D
    Kardiol Pol; 2004 Dec; 61(12):624-7. PubMed ID: 15815771
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.